Product Information
AURYXIA 210 MG TABLET is a brand product labeled by Akebia Therapeutics, Inc., priced at $7.4809 per EA under NDC 59922063101. Its NADAC has been published 558 times since Oct 21, 2015.
Strength
210 mg/1
Manufacturer
Akebia Therapeutics, Inc.NDC
59922063101
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
TETRAFERRIC TRICITRATE DECAHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA205874On Market Since
9/17/2014
Pharmacological Classes
Price Statistics
The NADAC for AURYXIA 210 MG TABLET has been published 558 times since Oct 21, 2015, and over the history we have for it it has risen 69.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.4809 per EA |
|---|---|
| All-time high | $7.4809 (Jun 24, 2026) |
| All-time low | $4.4266 (Oct 21, 2015) |
| 52-week high | $7.4809 |
| 52-week low | $7.4174 |
| Median price | $6.1307 |
| Average price | $6.0897 |
| Largest weekly change | +9.9% (Jul 6, 2016) |
| Weeks tracked | 558 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ferric citrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AURYXIA 210 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AURYXIA 210 MG TABLET, manufactured by Akebia Therapeutics, Inc., is $7.4809 per EA (NDC 59922063101), effective Jun 24, 2026.
How has the price of AURYXIA 210 MG TABLET changed over time?
Over the history we have for it, the NADAC for AURYXIA 210 MG TABLET has risen 69.0%. It has been tracked across 558 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for AURYXIA 210 MG TABLET?
Since Oct 21, 2015, the NADAC for AURYXIA 210 MG TABLET has ranged from a low of $4.4266 (Oct 21, 2015) to a high of $7.4809 (Jun 24, 2026), with a median of $6.1307 per EA.
Are there cheaper alternatives to AURYXIA 210 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AURYXIA 210 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures AURYXIA 210 MG TABLET?
AURYXIA 210 MG TABLET (NDC 59922063101) is labeled by Akebia Therapeutics, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification